Endothelial dysfunction is considered a sign of the early vascular changes preceding atherosclerosis. We studied the alteration of von Willebrand Factor (vWF), C -reactive protein (CRP), nitrite and Vascular Endothelial Growth Factor (VEGF) in a dietary reversal model of hypercholesterolemia in rabbit.
(like circulating endothelial cells and biochemical markers of ED) (ref. 2, 3 ). Of these methods, biomarkers are more practicable in a clinical setting: they are measured in easily obtained blood samples and can be standardized for use in clinical practice 4 . To date, there is no specifi c biomarker measurement that can be called a "gold standard" for ED assessment and it is recommended that ED should be investigated in a multifaceted approach 5 . Indeed, there are several factors which have been proposed as potential markers of endothelial cell activation and injury, and among ED biomarkers, the levels of vWF, CRP, nitrite and VEGF were investigated in this study [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Elevated vWF is perhaps the most known marker of endothelial injury 4, 5 . Raised CRP adds prognostic information on future cardiovascular risk at all levels of the Framingham risk score 8, 9 . Nitric Oxide (NO) stable metabolites [1] [2] [3] [4] such as nitrite have been reported to be good markers of endothelial NO production [15] [16] [17] while reduced NO bioactivity is known as an early event in atheroscle-
INTRODUCTION
Endothelial Dysfunction (ED) is a key variable in the pathogenesis of atherosclerosis and its complications. The presence of ED can be considered a clinical syndrome that is associated with and predicts adverse cardiovascular events 1 . Almost all risk factors that are related to atherosclerosis and cardiovascular disease including hyperlipidemia, hypertension, diabetes, and smoking are associated with ED. The ED is a switch that translates any given risk factor into unfavorable vascular eff ects. For this reason it is called the "ultimate risk of risk factors" 1 . ED measurement has important implications for cardiovascular disease management, such as primary prevention, evaluating the severity and prognosis of diseases and measuring treatment effi cacy 2 . Several approaches can be used to measure ED. These are categorized into functional assessment of ED (including fl ow-mediated dilation methods), structural markers of ED (such as IMT ratio) and cellular markers of ED rosis 15 . Another biomarker -VEGF is a vascular protective factor and functions as an endogenous regulator of endothelial integrity after injury 18 . It has been shown that VEGF and its receptors are up-regulated in vascular infl ammatory and proliferative disorders such as atherosclerosis and restenosis 19, 20 . Biomarkers have been investigated in patients in a number of studies 6, 7, 9, 10, 13, 14 . However, owing to the longstanding condition of the patients, it is not clear which biomarker changes in the early stage of atherosclerosis. This would provide very valuable information because detection of ED in the early stage of atherosclerosis would off er the chance of reversing the atherogenesis. This study was designed to investigate the eff ect of hypercholesterolemia as a risk factor of ED on ED biomarkers in a well-known model of atherosclerosis -the hypercholesterolemic rabbit 21 by measuring vWF, CRP, serum nitrite, and VEGF. These markers were chosen to provide a multifaceted approach to ED.
MATERIALS AND METHODS

Animals and Experimental design
The study was reviewed and approved by the Ethics Committee of Isfahan University of Medical Sciences.
Seventeen white male rabbits weighing 2 ± 0.2 kg were obtained from the Pasteur Institute of Iran.
After a 1-week acclimatization period and overnight fasting, venous blood samples were taken as pre-experimental sampling to obtain baseline data. Collected blood samples were centrifuged (10,000 × g), and the resulting supernatant, the serum or plasma, was stored at −70 °C until measurement. The plasma was used for vWF measurement and the serum for other biomarkers. The animals were then assigned to two groups. The animals in group HC (n = 11) were fed normal rabbit chow supplemented with 1 % cholesterol. A total of 6 rabbits were on normal chow as control group to investigate fatty streak formation. The normal rabbit chow components were starch (560 g/kg), fi ber (280 g/kg), grass meal (50 g/kg), fat mixture (40 g/kg), mineral mixture (39.5 g/kg), calcium carbonate and bisphosphate (25 g/kg) and vitamin mixture (5.5 g/kg). All animals received 150 g/day rabbit chow diet and water ad libitum. After 30 days of experiment (phase I), the blood samples were taken and stored again. Five animals from the HC group and three animals from control group were randomly selected, euthanized by an overdose of sodium pentobarbital and ex-sanguinated. The animal's aortas were harvested for pathological investigation. From this point, the hypercholesterolemic diet of the HC group was terminated and all animals were on a normal diet. The experiment was continued for other 30 days (phase II). At the end of the phase II, the blood sampling and storage were repeated. The rest of the animals were killed and the aortas harvested for pathological investigation.
Lipid and lipoprotein measurements
Total cholesterol, HDL cholesterol and LDL cholesterol levels were determined using standard enzymatic kits (Pars Azmoon Co, Iran).
Detection of endothelial markers
VWF (Cedarlane Co, Canada), VEGF (R&D systems, Minneapolis, USA) and CRP (IBL Co, Germany) were measured using enzyme-linked immuno-sorbent assay kits according to manufacturer's instructions. The serum level of nitrite was measured using a colorimetric assay kit (R&D Systems, USA) that involves the Griess reaction.
Pathological investigation
The abdominal aortas were subjected to pathological procedures to verify ED as fatty dots or fatty streak lesions. The entire aorta, from the aortic arch to the external iliac arteries, was dissected out and cleaned of excess adventitious tissue. The aortas were fi xed in buff ered 10 % formalin for 24 h and then embedded in paraffi n. The paraffi n-embedded specimens were sectioned at 5 μm (20 sections in succession), stained with haematoxylin and eosin and examined by light microscopy for fatty streaks by two pathologists in a double-blinded manner.
Fatty streak formation was determined by intima thickness and media thickness measurement in all sections. The data were averaged and used to obtain IMT ratio (Intima thickness/Media thickness).
Statistical analysis
The data are reported as the mean ± SEM. The statistical software package, SPSS (version 13), was used for the statistical analysis. The data were tested for normality and homogeneity of variance. Paired Student's t-test was used to assess the signifi cance of any change before and after treatment, while unpaired Student's t-test (equal or unequal variance assumed accordingly) was used to assess the signifi cance of any change between groups. The Spearman's rank correlation test was used to evaluate relationships between variables. The one sample t-test was used for IMT ratio data. Statistical signifi cance was accepted at p < 0.05.
RESULTS
Plasma lipids
The cholesterol-rich diet induced a signifi cant increase in total cholesterol, LDL-cholesterol and HDL-cholesterol within phase I of the study. After hypercholesterolemic diet withdrawal, total plasma cholesterol and LDL reduced signifi cantly but did not return to baseline values within phase II (Table 1 ).
Endothelial biomarkers
The (Table 1) . There was no signifi cant diff erence in vWF levels between baseline and the end of phase II.
The serum level of CRP signifi cantly increased by the end of the fi rst phase (2.90 ± 0.08 vs. 3.22 ± 0.1 μg/ml, p < 0.05) and signifi cantly decreased by the end of the second phase (2.7 ± .2 μg/ml, p < 0.05) ( Table 1) . No signifi cant diff erence in serum level of CRP was found between baseline and the end of phase II.
There was a trend towards increased serum level of VEGF by the end of phase I (202.95 ± 175.8 vs. 525.4 ± 205.2 pmol/L, p = 0.13) and also a trend towards decreased serum level of VEGF by the end of phase II (59.43 ± 26.6 pmol/L, p = 0.1) ( Table 1) . No signifi cant diff erence in serum level of VEGF was found between baseline and the end of phase II.
We found a trend towards increased serum level of nitrite by the end of the fi rst phase (8.86 ± 1.1 vs. 11.38 ± 1.8 μmol/L, p = 0.09) and a tendency to increase by the end of the second phase (19.4 ± 2.4 μmol/L, p = 0.07). At the end of phase II, the serum level of nitrite was signifi cantly diff erent from pre-experiment (p < 0.05) ( Table 1) .
Fatty streak formation
At the end of phase I, there were no fatty streak lesions in the control group aortas while the IMT ratio was 0.33 ± 0.1 in HC group (p = 0.07). At the end of phase II, the fatty streak lesion formation was signifi cantly higher in the HC group (0.49 ± 0.1 vs. 0, p < 0.05).
Endothelial biomarker correlations with cholesterol and fatty streaks in two phases of the study
There were signifi cant correlations between cholesterol and serum levels of nitrite (r = 0.621, p < 0.05) and CRP (r = 0.91, p < 0.05) by the end of the fi rst phase of experiment, but there was no correlation between cholesterol and serums levels of vWF and VEGF in this phase.
In the second phase of the study, only cholesterol had a strong correlation with serum levels of nitrite (r = 0.98, p < 0.05).
IMT ratio had a strong correlation with vWF (r = 0.87, p < 0.05) and serum nitrite (r = 0.75, p < 0.05) after the fi rst phase of the experiment. In the end of the study, the IMT ratio correlated with vWF (r = 84 %, p < 0.05) and with serum level of nitrite (r = -0.99, p < 0.05). No statistical correlations were found among other parameters such as NO and VEGF, CRP or vWF.
DISCUSSION
The cholesterol-rich diet induced a signifi cant increase in total cholesterol, LDL-cholesterol and HDL-cholesterol in the fi rst phase of the study. After hypercholesterolemic diet withdrawal, plasma lipids reduced signifi cantly but did not return to baseline values within 30 days. In this model, the cholesterol-rich diet resulted in the development of early lesions that were representative of fatty streak initiation similar to those in humans. Thus, the model allowed us to examine the initiation of atherosclerosis and risk factor eff ects after hypercholesterolemic diet withdrawal 21, 22 . In a similar model of rabbit hypercholesterolemia with 0.5% cholesterol-rich diet, the achieved serum level of cholesterol was only one fourth of that observed in our study 23 . This diff erence may be partly due to higher amount of food administered in the present experiment. Hypercholesterolemia-induced vWF increment found in our study is similar to previous reports 4, 6, 7 . VWF decreased after cholesterol diet discontinuation (phase II) -a fi nding that is interesting in the light of previous studies in which treatment with lipid-lowering agents (i.e. fl uvastatin or fenofi brate) did not diminish plasma vWF concentration in hyperlipidemic patients 4 . Our results showed that vWF concentration did not correlate with the severity of hypercholesterolemia, which is contrary to the positive correlation between these parameters found in the study by Hernández et al. using a larger sample size of hypercholesterolemic rabbits 23 . Nonetheless, vWF had a strong positive correlation with fatty streak formation in both phases of our study. It is notable that vWF has been reported as a highly relevant biomarker of vascular disease in many other studies [3] [4] [5] [6] [7] 23 . CRP followed the changes of cholesterol throughout the study -increase after 30 days of hypercholesterolemic diet and decrease after the reversal. The former fi nding is in line with other studies 8, 9, 23, 24 . Concerning the latter, CRP decrement has been reported after statin therapy 12 .
In our experiment, elevated plasma CRP correlated with the severity of hypercholesterolemia -a fi nding that is interesting for it has not been observed in human patients 23 ; however it has been shown in another study with hypercholesterolemic rabbits 24 . In any event, the relationship of CRP to total cholesterol and LDL cholesterol remains equivocal and is currently unknown.
We found a trend towards increased VEGF in the fi rst 30 days which decreased after cholesterol withdrawal. Increased plasma VEGF levels in atherosclerosis have been documented also by other authors 13, 14, 18, 19 . Although VEGF release may be a reparative mechanism in the early atherosclerosis 20 , it may also refl ect endothelial cell damage. VEGF decrement by lipid-lowering therapy has been demonstrated in patients with hyperlipidemia and atherosclerosis 13 . The present results indicated that 30 days of cholesterol-feeding (short-term hypercholesterolemia) enhanced the content of nitrite, as has been demonstrated previously [26] [27] [28] . Although decreased NO bioactivity has been attributed to ED (ref. 15 ) increased plasma level of nitrite has been reported in hypercholesterolemic patients too 29 .
Increased level of serum nitrite in our study is diff erent from similar studies with hypercholesterolemic rabbits which reported impaired endothelium-dependent relaxation accompanied by decreased NO production and reduced vessel cyclic guanosine monophosphate (cGMP) production 30 . It has been suggested that enhanced NO synthesis might be a defense mechanism to compensate for continuous inactivation of NO and protection against damaging factors 29, 31 . The proposed mechanism responsible for the elevation of nitrite may be a signifi cant increase in overall NOS synthesis by other cell types (than endothelium) in advanced lesions composed of the endothelial, neuronal and inducible isoforms of Nitric Oxide Synthase (NOS) enzymes. Despite decreased expression and activity of endothelial NO Synthase (eNOS) which has been indicated in some studies 30 , there are several studies that demonstrated the amount of NOS present in the atherosclerotic vessel wall to be substantially increased compared with normal vessels [32] [33] [34] . Increased NOS mRNA and protein in atherosclerosis is compatible with experiments showing that aortas of hypercholesterolemic rabbits release larger quantities of nitrogen oxides than do normal vessels 32 . Furthermore, using pharmacological probes has suggested that there is an increased production of NO in nonendothelial layers of vessels from hypercholesterolemic animals 35 . Increased endothelial constitutive NOS Protein and mRNA in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation 33 may be explained by inactivation of NO by oxygen-derived free radicals or masking the increased NO by increased production of endothelium-derived constricting factors.
Another explanation for the discrepancy between the results of these studies may be regional variation in eNOS activity. It has been shown that the eNOS activity in normocholesterolemic rabbits is signifi cantly higher in the downstream regions of aorta compared with the regions located more upstream such as aortic arch and thoracic aorta 36 . In our study nitrite as a NO metabolite correlated with fatty streak formation in both steps of experiment; however positively correlated in the fi rst phase and negatively correlated in the second phase. Further studies are needed to shed light on the underlying mechanisms.
CONCLUSION
The aim of the present study was to investigate the impact of early atherosclerosis as a disease state on the known biomarkers of ED. Among these biomarkers vWF, CRP, and VEGF followed risk factor alteration, and nitrite gradually increased during the study along with fatty streaks. Of these markers, vWF and NO signifi cantly correlated with fatty streak formation but only vWF had consistent positive correlation therewith. This study suggests that CRP and VEGF are not signifi cant predictors of atherosclerosis progression. It seems that vWF is the best biological marker for identifying the risk of developing atherosclerosis as a disease state in our study; however it is doubtful that a single biomarker provides appropriate information for all clinical settings associated with other types of risk factors.
Further eff ort is needed to improve the reliability and reproducibility of these results.
